Protecting Your Drinking Water

 

Everyone wants the best quality drinking water. Who produces the best drinking water – public or private companies?

Elizabeth Warren, naturally, has a plan. Like all of her plans, it calls for more government control. But statistics show that private companies do a better job.

Seth M. Siegel is a self-described drinking-water activist who is the author of Troubled Water: What’s Wrong With What We Drink. Siegel writes in The Wall Street Journal that 85% of drinking water utilities are owned and managed by municipalities and other public entities. The rest are controlled by private companies, some closely held, others publicly traded. A recent report from the National Academy of Sciences concluded that for-profit companies do a better job than government entities at removing contaminants from drinking water.

You may be surprised, as I was, to learn there are over 50,000 water suppliers in the U.S., many times the combined number of electricity and gas utilities. This amounts to more than 16 water utilities for every U.S. county! They are not all in rural counties. Los Angeles County has more than 200 of them. In all, 92% of drinking-water utilities serve 10,000 or fewer customers each.

This large number of water suppliers increases inefficiency and waste. More importantly, it adversely affects the quality of water. Siegel says, “The smaller the drinking-water utility, the greater the likelihood that it lacks the funds needed to hire highly skilled engineers, buy new treatment equipment, and replace aging infrastructure.”

This also impacts violations of the Safe Drinking Water Act. Siegel says, “Government companies are nearly 30% more likely than their private counterparts to incur violations of the Safe Drinking Water Act, according to a 2016 study in the American Journal of Political Science. Many of these violations go on for years, subjecting millions to water with unsafe levels of contaminants.”

There are reasons for these differences. Private water companies are subject to a layer of regulatory oversight from state public utility commissions from which municipal utilities are ordinarily exempt. When violations are found, regulators are often reluctant to hit small municipalities with fines, and are quicker to punish violations of private operators. That fear of a financial penalty encourages private companies to be more vigilant.

Yet Senator Warren would have us believe that more government-run utilities would give us more high-quality drinking water.

Solutions

Siegel suggests the following solutions:

  • Consolidation of utilities beginning with serial violators
  • Incentives for smaller communities to merge with larger neighbors
  • Sell local water services to private companies or outsource their management

 

Each of these solutions is aimed at encouraging larger companies, both private and public, that have greater resources to modernize their equipment, invest in infrastructure, and become more efficient through mergers.

Warren supports legislation introduced in the Senate by Bernie Sanders that would provide incentives for communities to terminate contracts with private water suppliers and restore water utilities to public ownership and management. This is no solution at all. It would eliminate the best of the water suppliers and discourage the mergers that would lead to more modern methods of assuring high quality drinking water. Eliminating competition by private water suppliers is a dangerous step in the wrong direction.

 

The Obama Medicaid Scam

 

President Obama is responsible for the greatest expansion of Medicaid in its history. What was once a healthcare safety net for lower-income children, pregnant women, adult caretakers, seniors, and the disabled is now providing coverage for able-bodied adult males, many of whom make far more money than the Federal Poverty Level (FPL).

Brian Blase and Aaron Yelowitz, writing in The Wall Street Journal, expose the truth about how much Medicaid eligibility has really expanded. They say in 2014, when the expansion started, the feds stopped doing audits of states’ Medicaid eligibility determinations. The Obama administration’s goal was to build public support for the new law by signing up as many people as possible, regardless of eligibility. Now, after a four-year hiatus, the Centers for Medicare and Medicaid Services (CMS) have begun auditing program eligibility again.

In a recently released report, audits found “high levels of observed eligibility errors,” meaning a significant number of people are enrolled in Medicaid who shouldn’t be.

Blase and Yelowitz analyzed the CMS report and suggest that the expansion appears to have more than tripled the amount of improper spending in the program. Twenty percent or more of Medicaid spending in 2019 – an amount likely to exceed $75 billion – is improper. Before ObamaCare, the Medicaid improper payment rate was only 6%.

Obama expanded eligibility to include those with incomes up to 138% of FPL, about $17,000 for a single person in 2019. Under the old Medicaid eligibility rules, states determined eligibility and some income limits were as low as 25% of FPL (Alabama). Although Obama tried to force all states to comply with his new rules, The Supreme Court determined this was unconstitutional and states were allowed to accept or reject the new rules. ObamaCare tried to incentivize states to expand by paying 100% of the increase in costs for the first three years, but only 90% thereafter.

Because of these incentives, states prefer to add patients as expansion enrollees, even if they qualified under the old rules. States receive reimbursement for old enrollees under the old rates, about 50% of costs. Higher overall Medicaid payments came with benefits for state-level interest groups that profited from maximizing enrollment. Insurers have reaped substantial profits from the Medicaid expansion – owing in part to large government payments for people who are enrolled but don’t go to the doctor or use much medical care.

Since states benefit from newly enrolled patients, they have no incentive to be sure they are eligible. One federal audit by the Health and Human Services Department’s inspector general found that more than half of sampled enrollees in California’s Medicaid program were either improperly enrolled or potentially improperly enrolled.

Blase and Yelowitz say this occurs more commonly in those states that expanded Medicaid under ObamaCare. The most severe are California, Kentucky, New Mexico, New York, and West Virginia. They estimate between 2.3 million and 3.3 million people with income above eligibility thresholds are enrolled in Medicaid in expansion states. In some areas, such as New York City or Los Angeles, the problem appears so large it suggests purposeful and fraudulent abuse on the part of local officials and the medical industry.

The irony of this crisis is that Medicaid has been shown in several studies to be worse than no insurance at all when it comes to controlling blood pressure, blood glucose levels in diabetes, and other common medical conditions. This is because Medicaid reduces access to healthcare since reimbursement rates to providers are so low. This is just another example of how the Obama administration promoted Medicaid expansion at the expense not only of taxpayers, but all those who receive their healthcare through this flawed system.

Colonoscopy or Cologuard? Which is Best for You?

 

Colon cancer is the third leading cause of cancer in the United States in both men and women. When identified in the early stages it is curable. But if it has already metastasized, the prognosis is grim. Therefore, screening for colon cancer is vitally important.

If you’re over the age of 50, you’ve probably already had a colonoscopy to screen for colon cancer. But lately, you may have heard about a new screening test, called Cologuard. No unpleasant bowel preparation; no trip to the doctor’s office, no IV sedation, no anesthesia hang-over, no colonoscopy! Sounds great. No more colonoscopy, right?

The Cologuard advertisements report 92% effectiveness in identifying colon cancer. You simply provide a stool sample in the privacy of your home, place it in the kit provided, and mail it in using UPS, shipping costs prepaid. It’s certainly easier than colonoscopy but how does it compare to colonoscopy or other screening methods?

Chris Conover, Duke University economist, recently studied this question for personal reasons and summarizes his findings:

Screening Methods

  • Colonoscopy – the best life expectancy per decade. Required once per 10 years.
  • Cologuard – loses 5.5 – 9.5 days of life expectancy per decade compared to colonoscopy. It is required every 3 years.
  • Sigmoidoscopy – a shorter version of colonoscopy requiring less bowel preparation but still invasive and (hopefully) involving sedation. It is required every 5 years instead of the 10 years for colonoscopy. Statistically, it loses 3.7 – 7.0 days of life expectancy per 10 years compared to colonoscopy.
  • Annual Fecal Tests – These come in two varieties; FIT– fecal immunochemical test and qFOBT– guiac based fecal occult blood test. Either test means 9 more trips to the doctor’s office and loses 3.7 to 6.9 days of life per decade compared to colonoscopy.

 

Cost Effectiveness

You may not care much about cost-effectiveness but the federal government certainly does. Cologuard is actually the least cost-effective of all the screening methods as this graphic shows:

Cologuard, however, is cost effective when compared to no screening at all. In a recent study, Cologuard cost $923 more per person per ten years than no screening. But it yielded an additional 28.9 days of life expectancy for the average senior. This means the cost per added year of life for Cologuard relative to no screening is $11,639. If Cologuard were the only screening test available, this would be extremely cost effective. But given that there are other screening methods that achieve greater benefits in life-years gained (colonoscopy), Cologuard at its current level of technology and price is actually cost-ineffective.

This tells us that the average ten-year cost of using Cologuard is about $1200 higher than for colonoscopy. Currently, both are available and paid for by most health insurance including Medicare. But if we ever go to a socialized medicine, government-controlled, single-payer system, (like Medicare for All) you can be sure the government will eliminate more costly methods of screening.

For now, the gold standard for detecting colon cancer is colonoscopy every ten years. I’ve done colonoscopy and Cologuard and there is no comparison when it comes to patient convenience and comfort. However, the best recommendation for detecting early colon cancer is both; Cologuard every 3 years and colonoscopy every 10 years. Be happy you have a choice now to do both because the time may come soon when you don’t.